Deoxynucleotide Triphosphates (dNTPs) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 157 SKU: IRTNTR76776

Deoxynucleotide Triphosphates (dNTPS) Market 2024-2028 

The Deoxynucleotide Triphosphates (dNTPS) Market size is estimated to grow at a CAGR of 7.26% between 2023 and 2028. The market size is forecast to increase by USD 77.45 million. The growth of the market depends on several factors such as the rising prominence of PCR in the biomedical sector, expanding applications of DNA sequencing, and increasing DNA synthesis procedures. 

The report includes a comprehensive outlook on the Deoxynucleotide Triphosphates dNTPS Market, offering forecasts for the industry segmented by product type which comprises liquid dNTPS, and solid dNTPS. Additionally, it categorizes application into research institutions, pharmaceutical and covers Geography regions, including North America, Europe, Asia, and Rest of World (ROW). The report provides market size, historical data spanning from 2018 - 2022, and future projections, all presented in terms of value in USD million for each of the mentioned segments.

What will be the size of the Deoxynucleotide Triphosphates dNTPS Market During the Forecast Period?

For More Highlights About this Report, Download Free Sample in a Minute 

Deoxynucleotide Triphosphates dNTPS Market: Key Drivers, Trends and Challenges

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Deoxynucleotide Triphosphates dNTPS Market Driver 

Expanding applications of DNA sequencing are notably driving the market growth. Deoxynucleotide triphosphates dNTPS are used in labs for a myriad of applications, including DNA sequencing. DNA sequencing is gaining prominence in many areas, including biology and other sciences, such as forensics, anthropology, and medicine, due to its increasing number of applications. DNA sequencing has a wide range of applications that range from the determination of the entire genome of any organism to the sequencing of individual genes. In molecular biology, DNA sequencing is used to identify the genetic mutations associated with several diseases as well as potential therapeutic targets for effective treatment. DNA sequencing is also used to study evolutionary history as genetic information is transferred from one generation to the next.

Moreover, DNA sequencing is considered a key analytical tool in forensics. Sequencing is usually performed along with DNA profiling procedures for forensic identification as well as paternity testing. Some major investigative samples include hair follicles, saliva, and fingerprints, all of which present unique and individualized DNA patterns that separate each living organism from others. Therefore, the expanding applications of DNA sequencing are likely to drive the growth of the market during the forecast period.

Key Deoxynucleotide Triphosphates dNTPS Market Trends

The rising use of oligonucleotides as therapeutic and diagnostic tools is an emerging trend shaping the market growth. 

The biomedical sector is witnessing significant use of oligonucleotides, which include short, single- or double-stranded DNA or RNA molecules in vitro diagnosis and therapeutics owing to their high specificity and excellent sensitivity. Genetic diagnosis of targets, peptides, small molecules, and proteins are some applications where oligonucleotide is considerably used.  Promising opportunities in antisense oligonucleotide technology have surged the demand for oligonucleotide synthesis for therapeutic manufacturing.

Additionally, the deoxynucleotide triphosphates (dNTPS) market is observing a rising demand from the pharmaceutical and biotechnology sectors owing to the increasing commercial approval of oligonucleotide therapies by authorities such as the US FDA and EMA. Thus, the growing commercial availability of oligonucleotide therapies is expected to positively impact the growth of the global deoxynucleotide triphosphates (dNTPS) market during the forecast period.

Major Deoxynucleotide Triphosphates dNTPS Market Challenge

Stringent regulations related to dNTPS are a significant challenge hindering market growth.  Variation in regulatory standards and compliances globally is among the primary challenges faced by vendors in the global deoxynucleotide triphosphates (dNTPS) market. Vendors offer deoxynucleotide triphosphates dNTPS that are used in highly regulated applications such as research and drug discovery, which expose their products to strict compliance requirements in terms of accuracy, quality, safety, and performance. Lack of specificity and variation in regulatory standards can create confusion during product compliance among deoxynucleotide triphosphates (dNTPS) market vendors. Failure in compliance can restrict the commercial entry of new products or result in the recall or discontinuation of an already commercialized product. This can adversely impact vendors' businesses.

Moreover, to get approval in such a complex regulatory structure, deoxynucleotide triphosphates market vendors largely rely on third parties that offer consulting services for regulatory compliance. This increases their reliance on third parties and creates a demand for additional investments, resulting in a financial burden. Thus, stringent regulations in the market will negatively impact the market in focus during the forecast period.

Deoxynucleotide Triphosphates dNTPS Market Customer Landscape

The market research report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Deoxynucleotide Triphosphates dNTPS Market Customer Landscape

Who are the Major Deoxynucleotide Triphosphates dNTPS Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

biotechrabbit GmbH - The company offers deoxynucleotide triphosphates (dNTPS) namely biotechrabbit deoxynucleotide triphosphates.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • BR Biochem Life Sciences Pvt. Ltd.
  • Central Glass Co. Ltd.
  • Creative Biogene
  • Geneaid Biotech Ltd.
  • Hefei Huana Biomedical Technology Co. Ltd.
  • Hzymes Biotechnology Co. Ltd.
  • Jena Bioscience GmbH
  • Larova GmbH
  • Maravai LifeSciences Holdings Inc.
  • MCLAB
  • Merck KGaA
  • Meridian Bioscience Inc.
  • Promega Corp.
  • SBS Genetech Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Wizbiosolutions Inc.
  • WUHU HUAREN SCIENCE AND TECHNOLOGY CO. LTD.
  • New England Biolabs Inc.
  • Takara Bio Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

What are the Largest-Growing Segments in the Deoxynucleotide Triphosphates dNTPS Market?

The liquid dNTPS are estimated to witness significant growth during the forecast period. Multiple concentrations of liquid dNTPS mix and solutions are suitable for molecular biology applications. The increasing incidence of infectious diseases and genetic disorders is leading researchers and scientists to opt for molecular biology solutions, including dNTPS, for the diagnosis and treatment of various infections. Researchers are increasingly focusing on molecular biology due to its high impact on diagnosing and treating diseases using gene therapy and recombinant vaccines. 

Get a glance at the market contribution of various segments Download the PDF Sample

The liquid dNTPS were the largest and were valued at USD 144.05 million in 2018. In recent years, the increasing prevalence of chronic diseases, such as cancer, among individuals is fueling the demand for early diagnosis of diseases to offer better patient care. Also, the incidence of infections caused by pathogens such as viruses and parasites is increasing, resulting in infections such as hepatitis and chronic viral infections. Hence, an increase in the prevalence of chronic and infectious diseases, coupled with the rising demand for the treatment of infectious diseases and genetic disorders using recombinant DNA technology, is expected to propel the growth of the segment and global deoxynucleotide triphosphates (dNTPS) market during the forecast period.

Which are the Key Regions for the Deoxynucleotide Triphosphates dNTPS Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The high growth of the deoxynucleotide triphosphates market in North America is majorly attributed to the presence of many testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical companies in this region. Countries such as the US and Canada are propelling the demand for dNTPS in this region owing to the increasing number of biomolecule research. North America has the largest number of cancer research institutions in the world that use dNTPS solutions for numerous applications, including analysis of several parameters in cancer patients. Research organizations require customized products for cancer-related research, which offers lucrative opportunities to the vendors for jointly developing innovative solutions and exploring new application areas. Such initiatives can help deoxynucleotide triphosphates market growth by developing innovative solutions and increasing product penetration in novel applications.

In addition, countries such as the US and Canada are witnessing a rise in investments in genomics research, which includes the application of deoxynucleotide triphosphates dNTPS for cloning and other applications. In September 2022, the Centers for Disease Control and Prevention (CDC) announced a funding of USD 90 to support the Pathogen Genomics Centers of Excellence (PGCoE) network. Thus, a rise in the number of genomics research activities is expected to drive the growth of the deoxynucleotide triphosphates (dNTPS) market in North America during the forecast period.

The COVID-19 outbreak in 2020 positively affected the regional market by directly influencing the production of and demand for dNTPS in PCR. Moreover, in 2021, the mass vaccination drives and ease of lockdown measures led to normalcy in the region, which led to the resumption of normal business in the region. Furthermore, the rising cases of chronic diseases such as cancer in the region are expected to fuel the growth of the deoxynucleotide triphosphates (dNTPS) market in the region during the forecast period.

Segment Overview

The deoxynucleotide triphosphates dNTPS market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Product Type Outlook 
    • Liquid dNTPS
    • Solid dNTPS
  • Application Outlook 
    • Research institutions
    • Pharmaceutical
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • South America
      • Chile 
      • Brazil
      • Argentina 
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Deoxynucleotide Triphosphates dNTPS Market Scope

Report Coverage

Details

Page number

157

Base year

2023

Historic period

 2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 7.26%

Market Growth 2024-2028

USD 77.45 million

Market structure

Fragmented

YoY growth 2023-2024(%)

6.7

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

biotechrabbit GmbH, BR Biochem Life Sciences Pvt. Ltd., Central Glass Co. Ltd., Creative Biogene, Geneaid Biotech Ltd., Hefei Huana Biomedical Technology Co. Ltd., Hzymes Biotechnology Co. Ltd., Jena Bioscience GmbH, Larova GmbH, Maravai LifeSciences Holdings Inc., MCLAB, Merck KGaA, Meridian Bioscience Inc., Promega Corp., SBS Genetech Co. Ltd., Thermo Fisher Scientific Inc., Wizbiosolutions Inc., WUHU HUAREN SCIENCE AND TECHNOLOGY CO. LTD., New England Biolabs Inc., and Takara Bio Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Deoxynucleotide Triphosphates dNTPS Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the market  size and its contribution to the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global deoxynucleotide triphosphates (dNTPs) market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global deoxynucleotide triphosphates (dntps) market 2018 - 2022 ($ million)
    • 4.2 Product Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Type Segment 2018 - 2022 ($ million)
    • 4.3 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Product Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Product Type
      • Exhibit 32: Chart on Comparison by Product Type
      • Exhibit 33: Data Table on Comparison by Product Type
    • 6.3 Liquid dNTPs - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Liquid dNTPs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Liquid dNTPs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Liquid dNTPs - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Liquid dNTPs - Year-over-year growth 2023-2028 (%)
    • 6.4 Solid dNTPs - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Solid dNTPs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Solid dNTPs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Solid dNTPs - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Solid dNTPs - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product Type
      • Exhibit 42: Market opportunity by Product Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product Type ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 44: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
    • 7.2 Comparison by Application
      • Exhibit 46: Chart on Comparison by Application
      • Exhibit 47: Data Table on Comparison by Application
    • 7.3 Research institutions - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Research institutions - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Research institutions - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Research institutions - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Research institutions - Year-over-year growth 2023-2028 (%)
    • 7.4 Pharmaceutical - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Pharmaceutical - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Pharmaceutical - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Pharmaceutical - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Pharmaceutical - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Application
      • Exhibit 56: Market opportunity by Application ($ million)
      • Exhibit 57: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 biotechrabbit GmbH
              • Exhibit 107: biotechrabbit GmbH - Overview
              • Exhibit 108: biotechrabbit GmbH - Product / Service
              • Exhibit 109: biotechrabbit GmbH - Key offerings
            • 12.4 Central Glass Co. Ltd.
              • Exhibit 110: Central Glass Co. Ltd. - Overview
              • Exhibit 111: Central Glass Co. Ltd. - Business segments
              • Exhibit 112: Central Glass Co. Ltd. - Key offerings
              • Exhibit 113: Central Glass Co. Ltd. - Segment focus
            • 12.5 Creative Biogene
              • Exhibit 114: Creative Biogene - Overview
              • Exhibit 115: Creative Biogene - Product / Service
              • Exhibit 116: Creative Biogene - Key offerings
            • 12.6 Geneaid Biotech Ltd.
              • Exhibit 117: Geneaid Biotech Ltd. - Overview
              • Exhibit 118: Geneaid Biotech Ltd. - Product / Service
              • Exhibit 119: Geneaid Biotech Ltd. - Key offerings
            • 12.7 Jena Bioscience GmbH
              • Exhibit 120: Jena Bioscience GmbH - Overview
              • Exhibit 121: Jena Bioscience GmbH - Product / Service
              • Exhibit 122: Jena Bioscience GmbH - Key offerings
            • 12.8 Maravai LifeSciences Holdings Inc.
              • Exhibit 123: Maravai LifeSciences Holdings Inc. - Overview
              • Exhibit 124: Maravai LifeSciences Holdings Inc. - Business segments
              • Exhibit 125: Maravai LifeSciences Holdings Inc. - Key offerings
              • Exhibit 126: Maravai LifeSciences Holdings Inc. - Segment focus
            • 12.9 MCLAB
              • Exhibit 127: MCLAB - Overview
              • Exhibit 128: MCLAB - Product / Service
              • Exhibit 129: MCLAB - Key offerings
            • 12.10 Merck KGaA
              • Exhibit 130: Merck KGaA - Overview
              • Exhibit 131: Merck KGaA - Business segments
              • Exhibit 132: Merck KGaA - Key news
              • Exhibit 133: Merck KGaA - Key offerings
              • Exhibit 134: Merck KGaA - Segment focus
            • 12.11 Meridian Bioscience Inc.
              • Exhibit 135: Meridian Bioscience Inc. - Overview
              • Exhibit 136: Meridian Bioscience Inc. - Business segments
              • Exhibit 137: Meridian Bioscience Inc. - Key offerings
              • Exhibit 138: Meridian Bioscience Inc. - Segment focus
            • 12.12 New England Biolabs Inc.
              • Exhibit 139: New England Biolabs Inc. - Overview
              • Exhibit 140: New England Biolabs Inc. - Product / Service
              • Exhibit 141: New England Biolabs Inc. - Key news
              • Exhibit 142: New England Biolabs Inc. - Key offerings
            • 12.13 Promega Corp.
              • Exhibit 143: Promega Corp. - Overview
              • Exhibit 144: Promega Corp. - Product / Service
              • Exhibit 145: Promega Corp. - Key offerings
            • 12.14 SBS Genetech Co. Ltd.
              • Exhibit 146: SBS Genetech Co. Ltd. - Overview
              • Exhibit 147: SBS Genetech Co. Ltd. - Product / Service
              • Exhibit 148: SBS Genetech Co. Ltd. - Key offerings
            • 12.15 Takara Bio Inc.
              • Exhibit 149: Takara Bio Inc. - Overview
              • Exhibit 150: Takara Bio Inc. - Business segments
              • Exhibit 151: Takara Bio Inc. - Key offerings
              • Exhibit 152: Takara Bio Inc. - Segment focus
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 153: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 154: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 155: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 156: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 157: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Wizbiosolutions Inc.
              • Exhibit 158: Wizbiosolutions Inc. - Overview
              • Exhibit 159: Wizbiosolutions Inc. - Product / Service
              • Exhibit 160: Wizbiosolutions Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 161: Inclusions checklist
                • Exhibit 162: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 163: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 164: Research methodology
                • Exhibit 165: Validation techniques employed for market sizing
                • Exhibit 166: Information sources
              • 13.5 List of abbreviations
                • Exhibit 167: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              deoxynucleotide triphosphates dntps market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis